EpirubicinCyclophosphamideTaxoidsAntineoplastic Combined Chemotherapy ProtocolsPaclitaxelDrug Administration ScheduleDoxorubicinBreast NeoplasmsFluorouracilAntibiotics, AntineoplasticAntineoplastic Agents, PhytogenicTreatment OutcomeVincristineAntineoplastic Agents, AlkylatingPhosphoramide MustardsCisplatinChemotherapy, AdjuvantDisease-Free SurvivalPrednisoneGranulocyte Colony-Stimulating FactorMethotrexateAntineoplastic AgentsNeutropeniaCombined Modality TherapyDose-Response Relationship, DrugLeukopeniaSurvival AnalysisDeoxycytidineInfusions, IntravenousNeoadjuvant TherapySurvival RateEtoposideVinblastineNeoplasm MetastasisAnthracyclinesMaximum Tolerated DoseImmunosuppressive AgentsRemission InductionNeoplasm StagingAlopeciaThiotepaIfosfamideLung NeoplasmsPulse Therapy, DrugMitoxantroneRazoxaneCarboplatinDrug Resistance, NeoplasmBusulfanPrednisoloneHematologic DiseasesAdenocarcinomaLymphoma, Non-HodgkinTime FactorsFollow-Up StudiesVomitingDrug Therapy, CombinationNauseaProstatic NeoplasmsAntibodies, Monoclonal, Murine-DerivedStomach NeoplasmsReceptor, erbB-2Neoplasm Recurrence, LocalDisease ProgressionNeoplasmsLymphatic MetastasisAntibodies, Monoclonal, HumanizedMethylprednisoloneVidarabineBone Marrow TransplantationHematopoietic Stem Cell TransplantationEstramustineCarcinoma, Non-Small-Cell LungAstheniaPrognosisDrug SynergismTransplantation, AutologousStomatitisAdministration, OralProspective StudiesAntibodies, MonoclonalWhole-Body IrradiationCystitisBone NeoplasmsInjections, IntravenousFeasibility StudiesAdministration, MetronomicMastectomy, RadicalKaplan-Meier EstimateDrug EvaluationCell Line, TumorCarmustineTegafurTransplantation ConditioningOvarian NeoplasmsMelphalanHematopoietic Stem Cell MobilizationBiotransformationBleomycinArea Under Curve